IKNA Insider Trading Activity and SEC Form 4 Filings
IKNA insider trading summary
No open-market insider purchases or sales of Ikena Oncology, Inc. (IKNA) have been reported on SEC Form 4 in the past 12 months.
Latest IKNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 24, 2022 | David P Bonita | Director | Buy | $516K (96,035 @ $5.37) |
| Jun 24, 2022 | Orbimed Advisors LLC | Director | Buy | $516K (96,035 @ $5.37) |
| Jun 24, 2022 | OrbiMed Genesis GP LLC | Director | Buy | $288K (65,965 @ $4.37) |
| Jun 24, 2022 | OrbiMed Capital GP VI LLC | Director | Buy | $516K (96,035 @ $5.37) |
| Jun 24, 2022 | OrbiMed Genesis GP LLC | Director | Buy | $516K (96,035 @ $5.37) |
| Jun 24, 2022 | David P Bonita | Director | Buy | $288K (65,965 @ $4.37) |
| Jun 24, 2022 | Orbimed Advisors LLC | Director | Buy | $288K (65,965 @ $4.37) |
| Jun 24, 2022 | OrbiMed Capital GP VI LLC | Director | Buy | $288K (65,965 @ $4.37) |
| Jun 23, 2022 | OrbiMed Genesis GP LLC | Director | Buy | $87K (23,419 @ $3.71) |
| Jun 23, 2022 | OrbiMed Capital GP VI LLC | Director | Buy | $87K (23,419 @ $3.71) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.